The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer's disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease. Provides an in-depth, broad perspective on the crisis in drug industry Exposes the disconnect between what society needs and what the drug companies are working on Analyses and projects over 10 years into the future Explains what it means for scientists and society Determines what is needed to be done to make sure that the industry responds to society's needs, remains commercially attractive and answers the question as to who decides which diseases to treat.
Bibliography, etc. Note
Includes bibliographical references and index.
Formatted Contents Note
00. Introduction 01. Why there will be new drugs despite the ongoing "crisis" of drug development in Big Pharma 02. The need for medicines grows 03. Medicines are becoming better : some of the breakthrough medicines of the past decades 04. Which diseases do we want to treat? 05. Therapeutic areas : strategically important diseases of the future 06. Blockbuster proprietary drugs versus generic drugs 07. Why is pharma a special industry? 08. Diagnosing toward personalized medicine 09. Personalized medicine 10. How much can drugs cost? 11. Modeling drug discovery until 2025 12. Drug development models between 2010 & 2025.